What: A doctor was indicted for writing an abortion pill prescription in a state where such care is banned.
Key line: [Details not provided].
Source: BBC.
What: A doctor was indicted for writing an abortion pill prescription in a state where such care is banned.
Key line: [Details not provided].
Source: BBC.
New Scientist explores how menopause affects the brain, describing it as a “renovation project.”
Breast cancer mortality decline stalled for women over 74.
Johns Hopkins researchers discuss the nuances of their findings on increased infant mortality after Texas abortion bans.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
Inc.’s Female Founders 500 list shows 18% of winners are health-related entrepreneurs.
Exploring new techniques to delay menopause, including ovarian freezing.
Studies reinforce that HRT timing may affect Alzheimer’s risk.
Study links higher menopausal symptom burden to dementia markers.
Texas Democrats push for maternal mortality transparency and tracking.
Context reports on the censorship faced by women’s health companies from Big Tech, with many ads rejected or content taken down.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
Pregnant federal workers lose jobs and face insurance gaps.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
Study shows over 50% of women don’t receive follow-up after cervical dysplasia treatment.
Study explores gene activation in women’s brains that may slow cognitive decline.
Trump’s FDA nominee suggests he’ll re-evaluate abortion pill safety.
McKinsey examines how AI is poised to revolutionize the beauty industry, from marketing to product development.
The Texas attorney general announced the arrest of a midwife accused of providing abortions despite the state’s ban.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
Rutgers researchers preserve and expand the Camden Study data.